Quick links

Secure login

Secure file transfer protocol

Register or renew user


Contact us

Trouble logging in? Forgot password? We can help!

philavax@phila.gov

215-685-6784

215-238-6944


Register a clinic

Fill out both forms, then either email or fax them to us at the contact above.

Clinic registration form
Provider agreement form

On behalf of patients

Request or update record
Patient update request

Looking for something else?

PhilaVax program info
Flat file reporting guide
More PhilaVax resources

VFC

2020 Enrollment begins February 3rd Happy new year! The Philadelphia Immunization Program annual Vaccines for Children (VFC) and Vaccines for Adults at Risk (VFAAR) enrollment opens on Monday, February 3rd. Start the new year off on the right foot. Complete your VFC/VFAAR enrollment on time. This year’s enrollment...

VFC/VFAAR Re-enrollment is right around the corner! The Philadelphia VFC/VFAAR annual re-enrollment period is November 1-30, 2018. Re-enrollment is a requirement for the VFC/VFAAR programs. Failure to complete the re-enrollment form will result in un-enrollment from the program. We’re very excited to announce that for the first...

ProQuad vaccine now available through the VFC program ProQuad is now available through the Philadelphia Vaccines for Children (VFC) program. ProQuad is a combination MMR (measles, mumps, and rubella) and Varicella vaccine. This combined vaccine lets you administer more vaccines with fewer injections. About ProQuad The CDC’s Advisory...

Treating pregnant women? Want to increase the use of maternal vaccines among your patients? Check out the CDC's new toolkit for prenatal providers....

Recommendations for the Meningococcal Serogroup B Vaccine The Philadelphia Department of Public Health is issuing recommendations on when healthcare providers should recommend and administer the meningococcal serogroup B (MenB) vaccine to patients. In October 2014 and January 2015, the FDA licensed two MenB vaccines for people...

The Philadelphia Department of Public Health is issuing recommendations on when healthcare providers should recommend and administer the meningococcal serogroup B (MenB) vaccine to patients. In October 2014 and January 2015, the FDA licensed two MenB vaccines for people age 10 to 25 years. Guidelines on...